Literature DB >> 2962641

Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin.

D L Higgins1, G A Vehar.   

Abstract

Tissue-type plasminogen activator (t-PA) plays a central role in fibrinolysis in vivo. Although it is known to bind to fibrin, the dissociation constant (Kd) and number of moles bound per mole of fibrin monomer (n) have never been measured directly. In this study, the binding of both the one-chain form and the two-chain form of recombinant, human t-PA to fibrin was measured. Although more one-chain t-PA than two-chain t-PA is bound to fibrin, the Kd's and n's were within experimental error of each other. Significantly more t-PA is bound to clots made from fibrinogen which has been digested with plasmin than to clots made from intact fibrinogen. The additional binding was shown to be due to the formation of new set(s) of binding site(s) with dissociation constants that are 2-4 orders of magnitude tighter than the binding site present on clots made from intact fibrinogen. epsilon-Aminocaproic acid was capable of competing for the loose binding site present on both intact and degraded fibrin but had little effect on the binding of t-PA to the new site(s) formed by plasmin digestion. This increase in binding caused by plasmin-mediated proteolysis of fibrin suggests a possible mechanism for a positive regulation capable of accelerating fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2962641     DOI: 10.1021/bi00398a038

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

Review 1.  Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.

Authors:  R Fears
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

2.  Inner clot diffusion and permeation during fibrinolysis.

Authors:  S L Diamond; S Anand
Journal:  Biophys J       Date:  1993-12       Impact factor: 4.033

3.  Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life.

Authors:  Mariko Nagashima; Zheng-Feng Yin; Lei Zhao; Kathy White; Yanhong Zhu; Nina Lasky; Meredith Halks-Miller; George J Broze; William P Fay; John Morser
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 4.  Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.

Authors:  D Collen; H R Lijnen; P A Todd; K L Goa
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

5.  Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.

Authors:  O F Wagner; C de Vries; C Hohmann; H Veerman; H Pannekoek
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

Review 6.  New insights into the role of Plg-RKT in macrophage recruitment.

Authors:  Lindsey A Miles; Shahrzad Lighvani; Nagyung Baik; Caitlin M Parmer; Sophia Khaldoyanidi; Barbara M Mueller; Robert J Parmer
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

7.  Expression of a novel chimeric truncated t-PA in CHO cells based on in silico experiments.

Authors:  Fatemeh Davami; Soroush Sardari; Keivan Majidzadeh-A; Mehdi Hemayatkar; Farzaneh Barkhrdari; Maryam Omidi; Mehrnaz Azami; Ahmad Adeli; Noushin Davoudi; Fereidoun Mahboudi
Journal:  J Biomed Biotechnol       Date:  2010-09-22

Review 8.  New strategies in the development of thrombolytic agents.

Authors:  H R Lijnen; D Collen
Journal:  Blut       Date:  1988-10

9.  Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain.

Authors:  M J Gething; B Adler; J A Boose; R D Gerard; E L Madison; D McGookey; R S Meidell; L M Roman; J Sambrook
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

10.  Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland.

Authors:  Y Yang; E Spitzer; D Meyer; M Sachs; C Niemann; G Hartmann; K M Weidner; C Birchmeier; W Birchmeier
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.